The participants recruited for this research had been Grownup Males and ladies above 20 years outdated and patients with ON who achieved the Intercontinental Classification of Headache Dysfunction (ICHD-3) diagnostic requirements. All individuals absolutely recognized the aims of this review and voluntarily agreed. The development and approval of Botulax during https://derma-solution.com/